Long non‑coding RNAs drive metastatic progression in melanoma (Review)
Akhbari, Pouria Whitehouse, A. Boyne, James R.
Akhbari, Pouria
Whitehouse, A.
Boyne, James R.
Publication Date
2014
End of Embargo
Supervisor
Rights
Peer-Reviewed
Yes
Open Access status
closedAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Metastatic melanoma is the leading cause of skin‑cancer related deaths and while in recent years some progress has been made with targeted therapies, there remains an urgent unmet need for novel therapeutic treatments and reliable diagnostic, prognostic and predictive biomarkers. The emergence of next generation sequencing (NGS) has seen a growing appreciation for the role played by non‑coding genomic transcripts in regulating gene expression and by extension impacting on disease progression. The long non‑coding RNAs (lncRNAs) represent the most enigmatic of these new regulatory molecules. Our understanding of how lncRNAs regulate biological functions and their importance to disease aetiology, while still limited, is rapidly improving, in particular with regards to their role in cancer. Herein we review the identification of several lncRNAs shown to impact on melanoma disease progression and discuss how these molecules are operating at the molecular level.
Version
No full-text in the repository
Citation
Akhbari P, Whitehouse A, and Boyne JR (2014) Long non‑coding RNAs drive metastatic progression in melanoma (Review). International Journal of Oncology. 45(6): 2181-2186.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article